Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 18347776)

Published in Diabetologia on March 18, 2008

Authors

K Swaminathan1, J Davies, J George, N S Rajendra, A D Morris, A D Struthers

Author Affiliations

1: Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. krishnan.swaminathan@nhs.net

Articles citing this

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol (2015) 1.50

Effect of spironolactone on physical performance in older people with self-reported physical disability. Am J Med (2013) 1.45

The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Pharmacol Sci (2011) 1.03

Targeting the renin-angiotensin-aldosterone system in heart failure. Nat Rev Cardiol (2013) 0.95

Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia (2011) 0.94

Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens (2013) 0.93

Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes (2014) 0.91

Effects of aldosterone on insulin sensitivity and secretion. Steroids (2014) 0.83

The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy. Hypertens Res (2015) 0.81

Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement. Am J Cardiol (2012) 0.79

Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study. J Hum Hypertens (2014) 0.77

Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.76

Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis. J Hum Hypertens (2015) 0.75

The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease. Curr Opin Nephrol Hypertens (2016) 0.75

Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis. BMC Cardiovasc Disord (2016) 0.75

Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Front Pharmacol (2015) 0.75

Articles by these authors

Transposition of R factor genes to bacteriophage lambda. Proc Natl Acad Sci U S A (1975) 9.28

Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene (1983) 8.79

Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol (1978) 8.35

Echocardiography in chronic heart failure in the community. Q J Med (1993) 7.64

Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem (1973) 7.08

Prophage induction and cell division in E. coli. III. Mutations sfiA and sfiB restore division in tif and lon strains and permit the expression of mutator properties of tif. Mol Gen Genet (1975) 6.82

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48

Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature (1991) 6.17

The problems of drug-resistant pathogenic bacteria. R factors: biochemical mechanisms of resistance to aminoglycoside antibiotics. Ann N Y Acad Sci (1971) 5.52

Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A (1973) 5.20

Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor. Biochemistry (1971) 5.01

"Infectious" transplantation tolerance. Science (1993) 4.98

Prophage induction and cell division in E. coli. I. Further characterization of the thermosensitive mutation tif-1 whose expression mimics the effect of UV irradiation. Mol Gen Genet (1972) 4.85

Transposition of an antibiotic resistance element in mycobacteria. Nature (1990) 4.85

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Expression of a transposable antibiotic resistance element in Saccharomyces. Nature (1980) 4.66

Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev (1968) 4.56

Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol Pharmacol (1965) 4.45

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44

Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA (2001) 4.30

QT dispersion and sudden unexpected death in chronic heart failure. Lancet (1994) 4.17

Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01

Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol (1996) 3.98

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia (2006) 3.94

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90

Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? Br Heart J (1995) 3.86

A distinctive class of integron in the Vibrio cholerae genome. Science (1998) 3.86

Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. BMJ (1997) 3.62

Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. Biochemistry (1972) 3.56

Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors. J Bacteriol (1969) 3.52

On the evolution of Tn21-like multiresistance transposons: sequence analysis of the gene (aacC1) for gentamicin acetyltransferase-3-I(AAC(3)-I), another member of the Tn21-based expression cassette. Mol Gen Genet (1989) 3.46

The isolation and partial characterization of a new restriction endonuclease from Providencia stuartii. Nucleic Acids Res (1976) 3.30

R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. FEBS Lett (1971) 3.28

[Prophage induction and cell division in E. coli. II. Linked (recA, zab) and unlinked (lex) suppressors of tif-1-mediated induction and filamentation]. Mol Gen Genet (1972) 3.25

Horizontal gene transfer and the origin of species: lessons from bacteria. Trends Microbiol (2000) 3.24

Genetic mapping of the regulator and operator genes of the lac operon. J Mol Biol (1968) 3.19

Enzymatic Adenylylation of Streptomycin and Spectinomycin by R-Factor-Resistant Escherichia coli. Infect Immun (1970) 3.02

Phenotypic suppression and misreading Saccharomyces cerevisiae. Nature (1979) 3.01

An SNP map of human chromosome 22. Nature (2000) 2.99

Resistance of Haemophilus influenzae to trimethoprim. Br Med J (1972) 2.89

Gene transfer between distantly related bacteria. Annu Rev Genet (1991) 2.88

A placental clock controlling the length of human pregnancy. Nat Med (1995) 2.86

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med (2008) 2.85

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83

Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics (1997) 2.81

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med (2005) 2.78

The evolutionary history of chromosomal super-integrons provides an ancestry for multiresistant integrons. Proc Natl Acad Sci U S A (2001) 2.77

Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol (2000) 2.71

Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. Proc Natl Acad Sci U S A (1974) 2.67

Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension (2000) 2.55

Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54

Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin. Antimicrob Agents Chemother (1978) 2.53

Inducible sfi dependent division inhibition in Escherichia coli. Mol Gen Genet (1980) 2.50

Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med (2000) 2.50

Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strain. J Hyg (Lond) (1970) 2.48

Enzymatic inactivation of streptomycin by R factor-resistant Escherichia coli. Nature (1968) 2.45

Antibiotic inhibition of group I ribozyme function. Nature (1991) 2.44

Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ (1996) 2.43

The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42

The genetics of bacterial ribosomes. Annu Rev Genet (1972) 2.41

Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. The effect of drug concentration. J Biol Chem (1968) 2.38

Enzymatic acetylation as a means of determining serum aminoglycoside concentrations. Antimicrob Agents Chemother (1973) 2.37

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (2010) 2.37

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J (1994) 2.32

Increased rates of illness and death from asthma in Canada. CMAJ (1987) 2.31

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet (1993) 2.30

Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29

A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg (1980) 2.28

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis (1975) 2.27

The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2010) 2.26

Effective dose from cone beam CT examinations in dentistry. Br J Radiol (2008) 2.25

Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin. Antimicrob Agents Chemother (1977) 2.22

Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22

Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ (1999) 2.14

Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12

Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass. Heart (2009) 2.12

CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J (2012) 2.11

Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10

Task-based learning: the answer to integration and problem-based learning in the clinical years. Med Educ (2000) 2.10

Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother (2000) 2.09

Indirect ultraviolet-reactivation of phage lambda. Proc Natl Acad Sci U S A (1974) 2.09

Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature (1974) 2.09

2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neurosci Lett (1981) 2.08

Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia (1977) 2.08

Microcloning reveals a high frequency of repetitive sequences characteristic of chromosome 4 and the beta-heterochromatin of Drosophila melanogaster. Proc Natl Acad Sci U S A (1988) 2.06

Further defining the role for natriuretic peptide levels in clinical practice. Eur Heart J (1999) 2.06

Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 2.05

Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05

Mode of action of thiolutin, an inhibitor of macromolecular synthesis in Saccharomyces cerevisiae. Antimicrob Agents Chemother (1973) 2.04

Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J (2002) 2.02

Further characterization of sfiA and sfiB mutations in Escherichia coli. J Bacteriol (1980) 2.01

Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut (1994) 1.97

Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96

Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J (1991) 1.96

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene (2011) 1.95